Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Diabetes|November 25, 2005
Natural history of type 1 diabetesPeter Achenbach, Ezio Bonifacio, Kerstin Koczwara, et al.
Diabetologia|September 14, 2018
Immunological biomarkers for the development and progression of type 1 diabetesChantal Mathieu, Riitta Lahesmaa, Ezio Bonifacio, et al.
Novartis Foundation Symposium|February 11, 2009
Translating mucosal antigen based prevention of autoimmune diabetes to humanEzio Bonifacio, Anette Ziegler, Peter Achenbach, et al.
Journal of Autoimmunity|November 7, 2002
Spontaneous peripheral T-cell responses to the IA-2beta (phogrin) autoantigen in young nonobese diabetic micePeter Achenbach, Katalin Kelemen, Dale R Wegmann, et al.
Diabetologia|September 18, 2023
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]Sandra Hummel, Nadine Friedl, Christiane Winkler, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2007
Identification of insulin autoantibodies of IgA isotype that preferentially target non-human insulinKerstin Koczwara, Daniela Muller, Peter Achenbach, et al.
Diabetologia|June 19, 2014
GAD autoantibody affinity in schoolchildren from the general populationChristine Bender, Michael Schlosser, Urs Christen, et al.
Diabetes Care|February 14, 2022
Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, GermanyFlorian M Karl, Christiane Winkler, Anette-Gabriele Ziegler, et al.
Diabetes Care|September 20, 2011
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2βMichael Schlosser, Patricia W Mueller, Peter Achenbach, et al.
Journal of Diabetes Research|July 17, 2018
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 DiabetesBeatriz Tavira, Hugo Barcenilla, Jeannette Wahlberg, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Diabetes|November 25, 2005
Natural history of type 1 diabetesPeter Achenbach, Ezio Bonifacio, Kerstin Koczwara, et al.
Diabetologia|September 14, 2018
Immunological biomarkers for the development and progression of type 1 diabetesChantal Mathieu, Riitta Lahesmaa, Ezio Bonifacio, et al.
Novartis Foundation Symposium|February 11, 2009
Translating mucosal antigen based prevention of autoimmune diabetes to humanEzio Bonifacio, Anette Ziegler, Peter Achenbach, et al.
Journal of Autoimmunity|November 7, 2002
Spontaneous peripheral T-cell responses to the IA-2beta (phogrin) autoantigen in young nonobese diabetic micePeter Achenbach, Katalin Kelemen, Dale R Wegmann, et al.
Diabetologia|September 18, 2023
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]Sandra Hummel, Nadine Friedl, Christiane Winkler, et al.
Clinical Immunology (Orlando, Fla.)|May 26, 2007
Identification of insulin autoantibodies of IgA isotype that preferentially target non-human insulinKerstin Koczwara, Daniela Muller, Peter Achenbach, et al.
Diabetologia|June 19, 2014
GAD autoantibody affinity in schoolchildren from the general populationChristine Bender, Michael Schlosser, Urs Christen, et al.
Diabetes Care|February 14, 2022
Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, GermanyFlorian M Karl, Christiane Winkler, Anette-Gabriele Ziegler, et al.
Diabetes Care|September 20, 2011
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2βMichael Schlosser, Patricia W Mueller, Peter Achenbach, et al.
Journal of Diabetes Research|July 17, 2018
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 DiabetesBeatriz Tavira, Hugo Barcenilla, Jeannette Wahlberg, et al.
Pageof 11